Amicus Therapeutics is building momentum with strong sales growth from GALAFOLD and POMBILITI/OPFOLDA. Click here to find out ...

Eli Lilly's growth is fueled by GLP-1 blockbusters and a solid pipeline, yet high valuations and reliance on key drugs ...

The FDA is requiring safety labeling changes to all opioid painkillers, to better highlight the risks posed by using the ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Dr George Tidmarsh, a former pharmaceutical executive who joined the FDA this month, will take over Prasad’s role temporarily.

President Trump escalated his demands that pharma firms lower U.S. prices in line with what other countries pay, sending ...

GSK signed a 12-asset licensing deal with Hengrui Pharma. Generic erosion on Vyvanse continued to hurt Takeda. Celltrion is ...

Novo Nordisk (NVO) stock shed over 21% on Tuesday after the Danish pharmaceutical giant slashed its guidance for the second time this year, leaving investors questioning whether the obesity drug ...

In the third part of her Pharma Commerce video interview, Heather Zenk, Cencora’s president of supply chain operations & ...

Key Points Revenue (GAAP) reached $124.1 million, surpassing the $115.5 million GAAP estimate and rising 29.7% year-over-year. Non-GAAP earnings per share improved to ($0.24), beating expectations and ...

President Trump escalated efforts to reduce drug prices in the US on Thursday, releasing letters sent to 17 pharmaceutical ...

Patient advocacy organizations across the United States are intensifying their efforts to expand access to experimental therapies, arguing that current regulatory frameworks create unnecessary ...